Skip to content
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
Read more about the article The drugs don’t work (and other mental health myths)

The drugs don’t work (and other mental health myths)

  • Post author:Olly PP
  • Post published:August 7, 2022
  • Post category:Industry News

Continue ReadingThe drugs don’t work (and other mental health myths)
Read more about the article Psychedelics: A neuroscientist’s guide to how they change your brain

Psychedelics: A neuroscientist’s guide to how they change your brain

  • Post author:Olly PP
  • Post published:August 1, 2022
  • Post category:Industry News

Continue ReadingPsychedelics: A neuroscientist’s guide to how they change your brain
Read more about the article Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up

Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up

  • Post author:Olly PP
  • Post published:August 1, 2022
  • Post category:Industry News

Continue ReadingRestrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up
Read more about the article Morgan Stanley: Counterpoint Global Insights Psychedelics

Morgan Stanley: Counterpoint Global Insights Psychedelics

  • Post author:Olly PP
  • Post published:July 27, 2022
  • Post category:Industry News

Continue ReadingMorgan Stanley: Counterpoint Global Insights Psychedelics
Read more about the article New study looks at ‘magic’ mushrooms as treatment for depression, without the psychedelic high

New study looks at ‘magic’ mushrooms as treatment for depression, without the psychedelic high

  • Post author:Olly PP
  • Post published:July 27, 2022
  • Post category:Industry News

Continue ReadingNew study looks at ‘magic’ mushrooms as treatment for depression, without the psychedelic high
Read more about the article Biden Administration Plans for Legal Psychedelic Therapies within Two Years

Biden Administration Plans for Legal Psychedelic Therapies within Two Years

  • Post author:Olly PP
  • Post published:July 26, 2022
  • Post category:Industry News

Continue ReadingBiden Administration Plans for Legal Psychedelic Therapies within Two Years
Read more about the article The Psychedelics Industry’s Next Hurdle Is How to Go Mainstream

The Psychedelics Industry’s Next Hurdle Is How to Go Mainstream

  • Post author:Olly PP
  • Post published:July 25, 2022
  • Post category:Industry News

Continue ReadingThe Psychedelics Industry’s Next Hurdle Is How to Go Mainstream
Read more about the article How safe is your psychedelic trip?

How safe is your psychedelic trip?

  • Post author:Olly PP
  • Post published:July 20, 2022
  • Post category:Industry News

Continue ReadingHow safe is your psychedelic trip?
Read more about the article No evidence that depression is caused by low serotonin levels, finds comprehensive review

No evidence that depression is caused by low serotonin levels, finds comprehensive review

  • Post author:Olly PP
  • Post published:July 20, 2022
  • Post category:Industry News

Continue ReadingNo evidence that depression is caused by low serotonin levels, finds comprehensive review
Read more about the article With ‘How to Change Your Mind,’ Taking a Trip With Michael Pollan

With ‘How to Change Your Mind,’ Taking a Trip With Michael Pollan

  • Post author:Olly PP
  • Post published:July 15, 2022
  • Post category:Industry News

Continue ReadingWith ‘How to Change Your Mind,’ Taking a Trip With Michael Pollan
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Go to the next page

Recent Posts

  • Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors
  • Albert Labs Management and Board of Director Announcement
  • Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology
  • Expansion of Drug Discovery and a Promising Pipeline
  • Albert Labs Announces Private Placement

Recent Comments

  • Randal Elliott on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Nicholas Stewart on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Camille Ortega on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Kelly Lambert on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Dean Phillips on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker

Innovative mental health medicines for patients with unmet needs

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy

© 2024 Albert Labs. All Rights Reserved

  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Twitter Linkedin Youtube Envelope
CSE:ABRT
FSE: VB50
CSE:ABRT
FSE: VB50

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact [email protected]

Twitter Linkedin Youtube Envelope

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

  • This field is for validation purposes and should be left unchanged.
Twitter
Youtube
Linkedin
Instagram
Envelope
Twitter
Youtube
Linkedin
Instagram
Envelope

Latest Press Release

Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors

Read more

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.